Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Renal cell carcinoma: the oncological outcome is not the only endpoint.
Martini A, Cumarasamy S, Hemal AK, Badani KK. Martini A, et al. Among authors: cumarasamy s. Transl Androl Urol. 2019 Mar;8(Suppl 1):S93-S95. doi: 10.21037/tau.2019.01.01. Transl Androl Urol. 2019. PMID: 31143678 Free PMC article. No abstract available.
Re: Rita Faria, Marta O. Soares, Eldon Spackman, et al. Optimising the Diagnosis of Prostate Cancer in the Era of Multiparametric Magnetic Resonance Imaging: A Cost-effectiveness Analysis Based on the Prostate MR Imaging Study (PROMIS). Eur Urol 2018;73:23-30.
Martini A, Gupta A, Cumarasamy S, Tewari AK. Martini A, et al. Among authors: cumarasamy s. Eur Urol. 2018 Apr;73(4):e108-e109. doi: 10.1016/j.eururo.2017.10.035. Epub 2017 Nov 11. Eur Urol. 2018. PMID: 29132712 No abstract available.
MRI-Targeted Biopsy for Prostate-Cancer Diagnosis.
Martini A, Cumarasamy S, Tewari AK. Martini A, et al. Among authors: cumarasamy s. N Engl J Med. 2018 Aug 9;379(6):589. doi: 10.1056/NEJMc1807507. N Engl J Med. 2018. PMID: 30091345 No abstract available.
Multiparametric Magnetic Resonance Imaging Features Identify Aggressive Prostate Cancer at the Phenotypic and Transcriptomic Level.
Beksac AT, Cumarasamy S, Falagario U, Xu P, Takhar M, Alshalalfa M, Gupta A, Prasad S, Martini A, Thulasidass H, Rai R, Berger M, Hectors S, Jordan J, Davicioni E, Nair S, Haines K 3rd, Lewis S, Rastinehad A, Yadav K, Jayaratna I, Taouli B, Tewari A. Beksac AT, et al. Among authors: cumarasamy s. J Urol. 2018 Dec;200(6):1241-1249. doi: 10.1016/j.juro.2018.06.041. Epub 2018 Jul 3. J Urol. 2018. PMID: 30563651
Defining Prostate Cancer at Favorable Intermediate Risk: The Potential Utility of Magnetic Resonance Imaging and Genomic Tests.
Falagario UG, Beksac AT, Martini A, Cumarasamy S, Gupta A, Prasad S, Thulasidass H, Shah QN, Jayaratna I, Lewis S, Rastinehad AR, Taouli B, Cormio L, Carrieri G, Tewari AK. Falagario UG, et al. Among authors: cumarasamy s. J Urol. 2019 Jul;202(1):102-107. doi: 10.1097/JU.0000000000000134. Epub 2019 Jun 7. J Urol. 2019. PMID: 30730408
23 results